If you're investing in a dividend stock, it's important to balance yield with risk. While you don't want to be too aggressive by looking for 10% dividend yields, you don't want to settle for nominal payouts either. Two stocks that pay at least 3% and are fairly safe buys over the long haul are Gilead Sciences (NASDAQ: GILD) and Campbell Soup (NYSE: CPB).
Earlier this month, Merck (NYSE: MRK) announced it was ending clinical trials of its antiviral pill candidate for treating COVID-19, molnupiravir, on account of the potential therapy's high level of effectiveness. Take Gilead Sciences' (NASDAQ: GILD) antiviral drug, remdesivir. Will Merck's drug follow a similar or better path?
Gilead Sciences (GILD) closed the most recent trading day at $67.24, moving +0.37% from the previous trading session.